260 309

Cited 6 times in

Hepatic fat quantification magnetic resonance for monitoring treatment response in pediatric nonalcoholic steatohepatitis

 Hong Koh  ;  Seung Kim  ;  Myung-Joon Kim  ;  Hyun Gi Kim  ;  Hyun Joo Shin  ;  Mi-Jung Lee 
 WORLD JOURNAL OF GASTROENTEROLOGY, Vol.21(33) : 9741-9748, 2015 
Journal Title
Issue Date
Adipose Tissue/metabolism ; Adipose Tissue/pathology* ; Adolescent ; Age Factors ; Biomarkers/blood ; Child ; Female ; Humans ; Liver/metabolism ; Liver/pathology* ; Magnetic Resonance Imaging* ; Male ; Medical Records ; Non-alcoholic Fatty Liver Disease/blood ; Non-alcoholic Fatty Liver Disease/pathology* ; Non-alcoholic Fatty Liver Disease/therapy* ; Patient Compliance ; Predictive Value of Tests ; Retrospective Studies ; Time Factors ; Treatment Outcome ; Young Adult
Child ; Hepatic fat quantification magnetic resonance ; Monitoring ; Nonalcoholic fatty liver disease ; Steatohepatitis
To evaluate the possibility of treatment effect monitoring using hepatic fat quantification magnetic resonance (MR) in pediatric nonalcoholic steatohepatitis (NASH). METHODS: We retrospectively reviewed the medical records of patients who received educational recommendations and vitamin E for NASH and underwent hepatic fat quantification MR from 2011 to 2013. Hepatic fat fraction (%) was measured using dual- and triple-echo gradient-recalled-echo sequences at 3T. The compliant and non-compliant groups were compared clinically, biochemically, and radiologically. RESULTS: Twenty seven patients (M:F = 24:3; mean age: 12 ± 2.3 years) were included (compliant group = 22, non-compliant = 5). None of the baseline findings differed between the 2 groups, except for triglyceride level (compliant vs non-compliant, 167.7 mg/dL vs 74.2 mg/dL, P = 0.001). In the compliant group, high-density lipoprotein increased and all other parameters decreased after 1-year follow-up. However, there were various changes in the non-compliant group. Dual-echo fat fraction (-19.2% vs 4.6, P < 0.001), triple-echo fat fraction (-13.4% vs 3.5, P < 0.001), alanine aminotransferase (-110.7 IU/L vs -10.6 IU/L, P = 0.047), total cholesterol (-18.1 mg/dL vs 3.8 mg/dL, P = 0.016), and triglyceride levels (-61.3 mg/dL vs 11.2 mg/dL, P = 0.013) were significantly decreased only in the compliant group. The change in body mass index and dual-echo fat fraction showed a positive correlation (ρ = 0.418, P = 0.030). CONCLUSION: Hepatic fat quantification MR can be a non-invasive, quantitative and useful tool for monitoring treatment effects in pediatric NASH.
Files in This Item:
T201503633.pdf Download
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Pediatrics (소아청소년과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Radiology (영상의학교실) > 1. Journal Papers
Yonsei Authors
Koh, Hong(고홍) ORCID logo https://orcid.org/0000-0002-3660-7483
Kim, Myung Joon(김명준) ORCID logo https://orcid.org/0000-0002-4608-0275
Kim, Seung(김승) ORCID logo https://orcid.org/0000-0003-4373-9828
Kim, Hyun Gi(김현지)
Shin, Hyun Joo(신현주) ORCID logo https://orcid.org/0000-0002-7462-2609
Lee, Mi-Jung(이미정) ORCID logo https://orcid.org/0000-0003-3244-9171
사서에게 알리기


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.